GB9914600D0 - Novel,process - Google Patents

Novel,process

Info

Publication number
GB9914600D0
GB9914600D0 GBGB9914600.3A GB9914600A GB9914600D0 GB 9914600 D0 GB9914600 D0 GB 9914600D0 GB 9914600 A GB9914600 A GB 9914600A GB 9914600 D0 GB9914600 D0 GB 9914600D0
Authority
GB
United Kingdom
Prior art keywords
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914600.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9914600.3A priority Critical patent/GB9914600D0/en
Publication of GB9914600D0 publication Critical patent/GB9914600D0/en
Priority to PCT/GB2000/002421 priority patent/WO2000078288A2/en
Priority to AU55507/00A priority patent/AU5550700A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB9914600.3A 1999-06-22 1999-06-22 Novel,process Ceased GB9914600D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9914600.3A GB9914600D0 (en) 1999-06-22 1999-06-22 Novel,process
PCT/GB2000/002421 WO2000078288A2 (en) 1999-06-22 2000-06-22 Novel process for paroxetine compositions
AU55507/00A AU5550700A (en) 1999-06-22 2000-06-22 Novel process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914600.3A GB9914600D0 (en) 1999-06-22 1999-06-22 Novel,process

Publications (1)

Publication Number Publication Date
GB9914600D0 true GB9914600D0 (en) 1999-08-25

Family

ID=10855850

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914600.3A Ceased GB9914600D0 (en) 1999-06-22 1999-06-22 Novel,process

Country Status (3)

Country Link
AU (1) AU5550700A (en)
GB (1) GB9914600D0 (en)
WO (1) WO2000078288A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
JP2001508460A (en) * 1997-01-15 2001-06-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Paroxetine composition
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations

Also Published As

Publication number Publication date
WO2000078288A3 (en) 2001-02-15
WO2000078288A2 (en) 2000-12-28
AU5550700A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
GB9905512D0 (en) Process
GB9920917D0 (en) Novel process
GB9908814D0 (en) Process
GB9924882D0 (en) Novel process
GB9914583D0 (en) Novel process
GB9904162D0 (en) Process
GB9914600D0 (en) Novel,process
GB9916392D0 (en) Novel process
GB9930577D0 (en) Novel process
GB9926908D0 (en) Novel process
GB9905418D0 (en) Process
GB9916187D0 (en) Novel process
GB9920147D0 (en) Novel process
GB9903087D0 (en) Process
GB9919001D0 (en) Novel process
GB9915303D0 (en) Novel process
GB9921243D0 (en) Novel process
GB9923539D0 (en) Novel process
GB9920146D0 (en) Novel process
GB9909973D0 (en) Process
ZA200109011B (en) New Process.
ZA200003273B (en) Process.
ZA992181B (en) Process.
GB9923439D0 (en) Novel process
GB9914585D0 (en) Novel process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)